neutral
Excelsoft Technologies IPO sees strong interest with over nine times subscription on Friday

Grey market trends indicate potential listing gains of up to 20% compared. With total bids reaching 27,85,40,500 shares against 3,07,01,754 shares on offer, reflecting 9.07 times demand. The Rs 500-crore book-building issue includes a fresh allotment of 1.5 crore shares worth Rs 180 crore and an offer-for-sale of 2.67 crore shares totaling Rs 320 crore. The price band has been fixed at Rs 114–120 per share. Retail investors must apply for a minimum lot of 125 shares, requiring an investment of Rs 15,000, while small non-institutional investors need 14 lots of 1,750 shares amounting to Rs 2,10,000. Grey market trends indicate potential listing gains of up to 20% compared with competing IPO Sudeep Pharma.
Companies:
- Excelsoft Technologies
- Sudeep Pharma
Tags:
- ipo
- markets
Explore:Mutual Fund Home
neutral
Excelsoft Technologies IPO sees strong interest with over nine times subscription on Friday

Grey market trends indicate potential listing gains of up to 20% compared. With total bids reaching 27,85,40,500 shares against 3,07,01,754 shares on offer, reflecting 9.07 times demand. The Rs 500-crore book-building issue includes a fresh allotment of 1.5 crore shares worth Rs 180 crore and an offer-for-sale of 2.67 crore shares totaling Rs 320 crore. The price band has been fixed at Rs 114–120 per share. Retail investors must apply for a minimum lot of 125 shares, requiring an investment of Rs 15,000, while small non-institutional investors need 14 lots of 1,750 shares amounting to Rs 2,10,000. Grey market trends indicate potential listing gains of up to 20% compared with competing IPO Sudeep Pharma.
Companies:
- Excelsoft Technologies
- Sudeep Pharma
Tags:
- ipo
- markets
Explore:Mutual Fund Home
1 min read
117 words

Excelsoft Technologies IPO is subscribed over nine times, with strong retail demand, defined lot sizes and grey market signals pointing to potential 20% upside.
Grey market trends indicate potential listing gains of up to 20% compared. With total bids reaching 27,85,40,500 shares against 3,07,01,754 shares on offer, reflecting 9.07 times demand. The Rs 500-crore book-building issue includes a fresh allotment of 1.5 crore shares worth Rs 180 crore and an offer-for-sale of 2.67 crore shares totaling Rs 320 crore. The price band has been fixed at Rs 114–120 per share. Retail investors must apply for a minimum lot of 125 shares, requiring an investment of Rs 15,000, while small non-institutional investors need 14 lots of 1,750 shares amounting to Rs 2,10,000. Grey market trends indicate potential listing gains of up to 20% compared with competing IPO Sudeep Pharma.

Grey market trends indicate potential listing gains of up to 20% compared. With total bids reaching 27,85,40,500 shares against 3,07,01,754 shares on offer, reflecting 9.07 times demand. The Rs 500-crore book-building issue includes a fresh allotment of 1.5 crore shares worth Rs 180 crore and an offer-for-sale of 2.67 crore shares totaling Rs 320 crore. The price band has been fixed at Rs 114–120 per share. Retail investors must apply for a minimum lot of 125 shares, requiring an investment of Rs 15,000, while small non-institutional investors need 14 lots of 1,750 shares amounting to Rs 2,10,000. Grey market trends indicate potential listing gains of up to 20% compared with competing IPO Sudeep Pharma.
Companies:
- Excelsoft Technologies
- Sudeep Pharma
Tags:
- ipo
- markets
- ipo
- markets
- Excelsoft Technologies
- GMP
- investing